BGB-A333, an anti-PD-L1 monoclonal antibody, in combination with tislelizumab in patients with urothelial carcinoma
Liberal, J. Martin, Fong, P.C., Moreno, V., Frentzas, S., Desai, J., Meniawy, T., Markman, B., Voskoboynik, M., Budha, N., Wu, J., Shen, W., Singh, M., Calvo, E.Volume:
31
Journal:
Annals of Oncology
DOI:
10.1016/j.annonc.2020.08.649
Date:
September, 2020
File:
PDF, 95 KB
2020